(Video): New Exon Skipping Drug in Clinical Development for Duchenne Muscular Dystrophy: Steve Hughes, MD, chief medical officer at AvidityBiosciences https://www.youtube.com/watch?v=XV56y_bwBZM PMO are #Morpholino